Sofinnova Partners Closes €725 Million Life Sciences Crossover Fund, Surpassing Predecessor by 63%
Sofinnova Partners has successfully raised €725 million for its second life sciences crossover fund, marking a significant increase of 63% compared to its predecessor. This substantial fundraising achievement underscores the…
